NYSE:MYOV
Myovant Sciences Ltd.
- Stock
industry
Biotechnologyexchange
New York Stock Exchangewebsite
myovant.comipo date
Oct 27, 2016full time employees
579currency
USD
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with ...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus